Drug Shortage Report for MEZAVANT

Last updated on 2020-08-22 History
Report ID 103353
Drug Identification Number 02297558
Brand name MEZAVANT
Common or Proper name Mesalamine delayed- and extended-release tablets
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) MESALAZINE
Strength(s) 1.2G
Dosage form(s) TABLET (DELAYED AND EXTENDED RELEASE)
Route of administration ORAL
Packaging size 120 tablets / bottle
ATC code A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-01-15
Actual start date 2020-01-15
Estimated end date 2020-08-20
Actual end date 2020-08-21
Shortage status Resolved
Updated date 2020-08-22
Company comments Constrained supply with product allocation
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-08-22 English Compare
v16 2020-08-21 French Compare
v15 2020-08-21 English Compare
v14 2020-07-30 French Compare
v13 2020-07-30 English Compare
v12 2020-04-28 French Compare
v11 2020-04-28 English Compare
v10 2020-04-28 French Compare
v9 2020-04-28 English Compare
v8 2020-01-16 English Compare
v7 2020-01-15 French Compare
v6 2020-01-15 English Compare
v5 2020-01-15 French Compare
v4 2020-01-15 English Compare
v3 2020-01-15 French Compare
v2 2020-01-15 English Compare
v1 2020-01-15 English Compare

Showing 1 to 17 of 17